# FYARRO

NDC: 80803-153
Generic name: Sirolimus
Labeler / Manufacturer: Aadi Bioscience, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20211206

FDA application: NDA213312

## Active ingredients

- SIROLIMUS: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"80803-153"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=80803-153
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0f9bb784-53e2-46f9-a65d-1c6c2a230eaf